erythromycin has been researched along with Stomach Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fushida, S; Hayashi, H; Hirakawa, K; Kinoshita, J; Miyashita, T; Ninomiya, I; Ohbatake, Y; Ohta, T; Oyama, K; Tajima, H; Takamura, H; Tsukada, T; Yashiro, M | 1 |
| Horikoshi, T; Kawamura, O; Kusano, M; Mori, M; Sekiguchi, T; Shimoyama, Y | 1 |
| Altomare, DF; D'Addabbo, A; Farese, S; Memeo, V; Pilot, MA; Rinaldi, M; Rubini, D; Rubini, G | 1 |
| Sillin, LF; Woodward, A | 1 |
| Altomare, DF; Baldassarre, G; Di Ciaula, A; Memeo, V; Moschetta, A; Palasciano, G; Portincasa, P; Rinaldi, M; vanBerge-Henegouwen, GP; Vendemiale, G; Venneman, NG | 1 |
| Inoue, Y; Ito, T; Kawahara, H; Matsuda, H; Nishida, T; Nishikawa, K; Yumiba, T | 1 |
| Harrison, JD; Jones, JA; Morris, DL | 1 |
| Gitinov, GG; Lunacharskaia, TV | 1 |
2 trial(s) available for erythromycin and Stomach Neoplasms
| Article | Year |
|---|---|
Oral erythromycin accelerates impaired gastrointestinal motility after endoscopic mucosal resection.
Topics: Adenoma; Administration, Oral; Adult; Aged; Dose-Response Relationship, Drug; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Erythromycin; Fasting; Follow-Up Studies; Gastric Mucosa; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Male; Middle Aged; Omeprazole; Postoperative Period; Stomach; Stomach Neoplasms; Treatment Outcome | 2007 |
The effect of acute oral erythromycin on gallbladder motility and on upper gastrointestinal symptoms in gastrectomized patients with and without gallstones: a randomized, placebo-controlled ultrasonographic study.
Topics: Administration, Oral; Anti-Bacterial Agents; Appetite; Cholelithiasis; Erythromycin; Female; Food, Formulated; Gallbladder; Gallbladder Emptying; Gastrectomy; Humans; Male; Middle Aged; Risk Factors; Satiation; Sensation; Stomach Neoplasms; Ultrasonography | 2000 |
6 other study(ies) available for erythromycin and Stomach Neoplasms
| Article | Year |
|---|---|
Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin.
Topics: Animals; Apoptosis; Ascites; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Mice; Orosomucoid; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Oral erythromycin improves gastrointestinal motility and transit after subtotal but not total gastrectomy for cancer.
Topics: Administration, Oral; Adult; Aged; Erythromycin; Female; Gastrectomy; Gastrointestinal Agents; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Male; Manometry; Middle Aged; Postoperative Period; Stomach Neoplasms | 1997 |
Oral erythromycin improves gastrointestinal motility and transit after subtotal but not total gastrectomy for cancer.
Topics: Administration, Oral; Anastomosis, Roux-en-Y; Erythromycin; Gastrectomy; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Stomach Neoplasms | 1998 |
Functional characteristics of the pylorus in patients undergoing pylorus--preserving gastrectomy for early gastric cancer.
Topics: Adult; Duodenum; Erythromycin; Female; Gastrectomy; Gastric Emptying; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Injections, Intravenous; Intubation; Lipids; Male; Manometry; Middle Aged; Postprandial Period; Pressure; Pylorus; Radionuclide Imaging; Stomach Neoplasms; Time Factors | 2002 |
Azithromycin levels in plasma and gastric tissue, juice and mucus.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Azithromycin; Chromatography, High Pressure Liquid; Erythromycin; Female; Gastric Juice; Gastric Mucosa; Humans; Male; Middle Aged; Mucus; Stomach; Stomach Neoplasms; Time Factors | 1991 |
[Gastric microbial flora and its sensitivity to antibiotics following a short-time use of the tetracyclines morphocycline and glycocycline].
Topics: Anti-Bacterial Agents; Bacillus; Bacteria; Chloramphenicol; Duodenal Ulcer; Enterococcus faecalis; Erythromycin; Erythromycin Ethylsuccinate; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Neomycin; Oleandomycin; Penicillin Resistance; Penicillins; Proteus; Pseudomonas aeruginosa; Staphylococcus; Stomach; Stomach Neoplasms; Stomach Ulcer; Streptococcus pneumoniae; Streptomycin; Tetracycline; Yeasts | 1970 |